Baby ABS (Abdominal Binder Study)
NCT: NCT07049900 · RECRUITING
Brief Summary
The primary outcome of this study is to determine if the use of the FDA-approved DandleLion NeoBellyBand increases the thickness of the rectus abdominis muscle in premature babies receiving continuous positive pressure ventilation, leading to infants reaching full oral feedings at an earlier corrected gestational age.
Frequently Asked Questions
What is Baby ABS (Abdominal Binder Study)?
Baby ABS (Abdominal Binder Study) is a clinical trial registered under NCT07049900. Current status: RECRUITING.
What is the status of NCT07049900?
The current status of NCT07049900 (Baby ABS (Abdominal Binder Study)) is: RECRUITING.
When did Baby ABS (Abdominal Binder Study) start?
Baby ABS (Abdominal Binder Study) started on 2025-01-22.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.